Table 1 Baseline demographic, clinical and biochemical characteristics of 22 patients with UC.
From: Remote ischemic conditioning in active ulcerative colitis: An explorative randomized clinical trial
Characteristic | RIC | Sham |
|---|---|---|
n = 11 | n = 11 | |
Age [years] | 41 [36–64] | 41 [24–50] |
Sex [female] | 2 [18%] | 9 [82%] |
Weight [kg] | 78.2 [70.8–91.2] | 70.0 [63.9–88.7] |
BMI [kg/cm2] | 25.4 [23.9–28.6] | 26.3 [22.6–28.4] |
Disease duration [years] | 13.2 [8.3–14.9] | 5.1 [2.2–12.3] |
Smoking status | ||
Current | 1 [9] | 0[0] |
Former | 7 [64] | 7 [64] |
Never | 3 [27] | 4 [36] |
Alcohol consumption | ||
≥7/14 alcohol units per week | 1 [9] | 2 [18] |
<7/14 alcohol units per week | 10 [91] | 5 [45] |
No alcohol | 0[0] | 4 [36] |
Disease extent at endoscopy | ||
Proctitis | 4 [36] | 6 [55] |
Left-sided UC | 5 [45] | 4 [36] |
Pancolitis | 2 [18] | 1 [9] |
Montréal classification | ||
E1 - Ulcerative proctitis | 3 [27] | 4 [36] |
E2 - Left sided UC [distal UC] | 7 [64] | 6 [55] |
E3 - Extensive UC [pancolitis] | 1 [9] | 1 [9] |
Medication | ||
No treatment | 4 [36] | 2 [18] |
Rectal 5-ASA | 2 [18] | 4 [36] |
Oral 5-ASA | 6 [55] | 8 [73] |
Immunosuppressants | 1 [9] | 1 [9] |
Anti-TNF | 0 | 0 |
FC | 1220 [523–1808] | 1391 [879–4139] |
P-CRP | 1.95 [1.8–8.3] | 1.9 [1.6–6.1] |
Mayo Score | 7 [6–8] | 8 [7–9] |
Endoscopic Mayo Score | 2 [2–2.5] | 2 [2–2.5] |
Days of flare prior to inclusion | 78 [22.5–150] | 41 [22–93] |
Days of RIC/Sham | 10 [9,10] | 10.5 [10,11] |
